COVAXIN

A health worker displays a vial of the Covaxin vaccine at a health centre in New Delhi. Photo: AFP via Hindustan Times
Coronavirus chronicle

Covaxin effective against Delta Plus variant, says ICMR study

India has undertaken one of the world's largest vaccination drives and so far distributed more than 430 million doses. Covaxin was given emergency use authorisation on January 3 this year

Boxes of Covid-19 vaccines, manufactured in India, arrive at the airport in Mogadishu, Somalia, in March. Photo :AP via Hindustan Times
Coronavirus chronicle

Indian government plans Covaxin trials in Bangladesh to enhance its recognition abroad

Covaxin is produced by Bharat Biotech and is one of the vaccines being used in the nationwide inoculation drive. Photo :AFP via Hindustan Times
Coronavirus chronicle

Covaxin to get WHO nod soon? Chief scientist says Covid-19 vaccine trial data 'looks good'

Covaxin demonstrates 93.4% efficacy against severe diseases
Coronavirus chronicle

Covaxin demonstrates 93.4% efficacy against severe diseases

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU
Coronavirus chronicle

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

In the case of procurement of Covaxin by Brazil, a step-by-step approach followed, Bharat Biotech said.
World+Biz

Bharat Biotech says it received no advance payment from Brazil govt for Covaxin

Covaxin is produced by Bharat Biotech and is one of the vaccines being used in the nationwide inoculation drive. Photo :AFP via Hindustan Times
Coronavirus chronicle

Covaxin 77.8% effective in phase 3 trial data

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

FDA rejects emergency use authorization of Bharat Biotech’s Covaxin jab

Amid row, Bharat Biotech says it will conduct phase 4 trial of Covaxin, phase 3 data to be out in July
Coronavirus chronicle

Amid row, Bharat Biotech says it will conduct phase 4 trial of Covaxin, phase 3 data to be out in July

Bharat Biotech's clarification comes at a time when the country is facing a shortage of Covid-19 vaccines, leading to disruptions in the nationwide inoculation programme.(Bloomberg)
Coronavirus chronicle

Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech

Covaxin is produced by Bharat Biotech and is one of the vaccines being used in the nationwide inoculation drive. Photo :AFP via Hindustan Times
Coronavirus chronicle

Covaxin trials on children expected to start in June: Bharat Biotech

Indian govt invites vaccine makers to produce Covaxin to address shortage
Coronavirus chronicle

Indian govt invites vaccine makers to produce Covaxin to address shortage

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's Covid-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Covid-19 in Bangladesh

Indian drug regulator okays Covaxin phase 2,3 clinical trial for 2-18 age group